nodes	percent_of_prediction	percent_of_DWPC	metapath
Lovastatin—UGT1A1—Etoposide—germ cell cancer	0.0709	0.093	CbGbCtD
Lovastatin—CYP3A7—Ifosfamide—germ cell cancer	0.0603	0.079	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Ifosfamide—germ cell cancer	0.0603	0.079	CbGbCtD
Lovastatin—ABCC2—Vinblastine—germ cell cancer	0.0479	0.0628	CbGbCtD
Lovastatin—CYP3A5—Ifosfamide—germ cell cancer	0.0452	0.0593	CbGbCtD
Lovastatin—ABCC2—Cisplatin—germ cell cancer	0.0439	0.0576	CbGbCtD
Lovastatin—CYP2C8—Ifosfamide—germ cell cancer	0.0435	0.057	CbGbCtD
Lovastatin—ABCC2—Etoposide—germ cell cancer	0.0432	0.0566	CbGbCtD
Lovastatin—CYP2C19—Ifosfamide—germ cell cancer	0.0365	0.0478	CbGbCtD
Lovastatin—SLCO1A2—Methotrexate—germ cell cancer	0.0344	0.0451	CbGbCtD
Lovastatin—SLCO1B1—Methotrexate—germ cell cancer	0.0325	0.0425	CbGbCtD
Lovastatin—CYP2C9—Ifosfamide—germ cell cancer	0.0303	0.0398	CbGbCtD
Lovastatin—ABCC2—Methotrexate—germ cell cancer	0.0285	0.0374	CbGbCtD
Lovastatin—ABCB1—Dactinomycin—germ cell cancer	0.0249	0.0327	CbGbCtD
Lovastatin—CYP3A5—Etoposide—germ cell cancer	0.0216	0.0283	CbGbCtD
Lovastatin—CYP2C8—Etoposide—germ cell cancer	0.0208	0.0272	CbGbCtD
Lovastatin—CYP3A4—Ifosfamide—germ cell cancer	0.0176	0.0231	CbGbCtD
Lovastatin—ABCB1—Vinblastine—germ cell cancer	0.0156	0.0205	CbGbCtD
Lovastatin—CYP2C9—Cisplatin—germ cell cancer	0.0148	0.0193	CbGbCtD
Lovastatin—CYP2D6—Vinblastine—germ cell cancer	0.0147	0.0193	CbGbCtD
Lovastatin—ABCB1—Cisplatin—germ cell cancer	0.0143	0.0188	CbGbCtD
Lovastatin—ABCB1—Etoposide—germ cell cancer	0.0141	0.0184	CbGbCtD
Lovastatin—CYP3A4—Vinblastine—germ cell cancer	0.00936	0.0123	CbGbCtD
Lovastatin—ABCB1—Methotrexate—germ cell cancer	0.0093	0.0122	CbGbCtD
Lovastatin—CYP3A4—Etoposide—germ cell cancer	0.00843	0.011	CbGbCtD
Lovastatin—CYP2C9—cardial valve—germ cell cancer	0.00691	0.0649	CbGeAlD
Lovastatin—ITGAL—endothelium—germ cell cancer	0.00502	0.0472	CbGeAlD
Lovastatin—ITGAL—blood vessel—germ cell cancer	0.00463	0.0435	CbGeAlD
Lovastatin—HDAC2—telencephalic ventricle—germ cell cancer	0.00374	0.0351	CbGeAlD
Lovastatin—UGT1A1—urine—germ cell cancer	0.00355	0.0333	CbGeAlD
Lovastatin—HDAC2—Teniposide—Etoposide—germ cell cancer	0.00316	1	CbGdCrCtD
Lovastatin—ITGAL—trigeminal ganglion—germ cell cancer	0.00286	0.0269	CbGeAlD
Lovastatin—ITGAL—decidua—germ cell cancer	0.00213	0.02	CbGeAlD
Lovastatin—CYP2C19—urine—germ cell cancer	0.00192	0.0181	CbGeAlD
Lovastatin—PON3—pituitary gland—germ cell cancer	0.00179	0.0168	CbGeAlD
Lovastatin—ITGAL—medulla oblongata—germ cell cancer	0.00176	0.0166	CbGeAlD
Lovastatin—ITGAL—adrenal gland—germ cell cancer	0.00163	0.0153	CbGeAlD
Lovastatin—ITGAL—midbrain—germ cell cancer	0.00161	0.0152	CbGeAlD
Lovastatin—ITGAL—bone marrow—germ cell cancer	0.00158	0.0148	CbGeAlD
Lovastatin—ITGAL—spinal cord—germ cell cancer	0.00157	0.0148	CbGeAlD
Lovastatin—PON3—bone marrow—germ cell cancer	0.00155	0.0146	CbGeAlD
Lovastatin—ITGAL—female gonad—germ cell cancer	0.00152	0.0143	CbGeAlD
Lovastatin—PON3—female gonad—germ cell cancer	0.00149	0.014	CbGeAlD
Lovastatin—CYP2C9—urine—germ cell cancer	0.00149	0.014	CbGeAlD
Lovastatin—ITGAL—endocrine gland—germ cell cancer	0.00142	0.0133	CbGeAlD
Lovastatin—PON3—endocrine gland—germ cell cancer	0.00139	0.0131	CbGeAlD
Lovastatin—ITGAL—testis—germ cell cancer	0.00135	0.0127	CbGeAlD
Lovastatin—PON3—testis—germ cell cancer	0.00132	0.0124	CbGeAlD
Lovastatin—HDAC2—neck—germ cell cancer	0.00132	0.0124	CbGeAlD
Lovastatin—ITGAL—cerebellum—germ cell cancer	0.00125	0.0117	CbGeAlD
Lovastatin—UGT1A3—endocrine gland—germ cell cancer	0.0012	0.0113	CbGeAlD
Lovastatin—HMGCR—neck—germ cell cancer	0.00119	0.0112	CbGeAlD
Lovastatin—HDAC2—trigeminal ganglion—germ cell cancer	0.00114	0.0107	CbGeAlD
Lovastatin—CYP3A4—urine—germ cell cancer	0.00114	0.0107	CbGeAlD
Lovastatin—ITGAL—Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell—PVRL2—germ cell cancer	0.00112	0.0673	CbGpPWpGaD
Lovastatin—CYP2D6—urine—germ cell cancer	0.00112	0.0105	CbGeAlD
Lovastatin—HDAC2—embryo—germ cell cancer	0.0011	0.0104	CbGeAlD
Lovastatin—HMGCR—trigeminal ganglion—germ cell cancer	0.00103	0.00969	CbGeAlD
Lovastatin—ITGAL—brain—germ cell cancer	0.00101	0.00952	CbGeAlD
Lovastatin—HDAC2—brainstem—germ cell cancer	0.00101	0.0095	CbGeAlD
Lovastatin—ABCB1—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.000999	0.0598	CbGpPWpGaD
Lovastatin—PON3—brain—germ cell cancer	0.000993	0.00934	CbGeAlD
Lovastatin—HDAC2—eye—germ cell cancer	0.000984	0.00925	CbGeAlD
Lovastatin—ITGAL—lymph node—germ cell cancer	0.000979	0.0092	CbGeAlD
Lovastatin—HDAC2—retina—germ cell cancer	0.000975	0.00917	CbGeAlD
Lovastatin—HDAC2—telencephalon—germ cell cancer	0.000897	0.00843	CbGeAlD
Lovastatin—HDAC2—skin of body—germ cell cancer	0.000856	0.00805	CbGeAlD
Lovastatin—HDAC2—decidua—germ cell cancer	0.00085	0.00799	CbGeAlD
Lovastatin—HMGCR—telencephalon—germ cell cancer	0.00081	0.00761	CbGeAlD
Lovastatin—HMGCR—skin of body—germ cell cancer	0.000773	0.00726	CbGeAlD
Lovastatin—HMGCR—decidua—germ cell cancer	0.000767	0.00721	CbGeAlD
Lovastatin—HDAC2—gonad—germ cell cancer	0.000749	0.00704	CbGeAlD
Lovastatin—HDAC2—uterus—germ cell cancer	0.000744	0.00699	CbGeAlD
Lovastatin—HDAC2—pituitary gland—germ cell cancer	0.00073	0.00687	CbGeAlD
Lovastatin—CYP3A7—endocrine gland—germ cell cancer	0.000713	0.00671	CbGeAlD
Lovastatin—HDAC2—medulla oblongata—germ cell cancer	0.000705	0.00663	CbGeAlD
Lovastatin—UGT2B7—endocrine gland—germ cell cancer	0.000691	0.0065	CbGeAlD
Lovastatin—UGT1A3—Metapathway biotransformation—NAT9—germ cell cancer	0.000685	0.041	CbGpPWpGaD
Lovastatin—HMGCR—gonad—germ cell cancer	0.000676	0.00635	CbGeAlD
Lovastatin—HMGCR—uterus—germ cell cancer	0.000671	0.00631	CbGeAlD
Lovastatin—UGT2B7—testis—germ cell cancer	0.000659	0.0062	CbGeAlD
Lovastatin—HMGCR—pituitary gland—germ cell cancer	0.000659	0.0062	CbGeAlD
Lovastatin—HDAC2—adrenal gland—germ cell cancer	0.000653	0.00613	CbGeAlD
Lovastatin—HDAC2—midbrain—germ cell cancer	0.000644	0.00606	CbGeAlD
Lovastatin—HMGCR—medulla oblongata—germ cell cancer	0.000636	0.00598	CbGeAlD
Lovastatin—HDAC2—bone marrow—germ cell cancer	0.000631	0.00593	CbGeAlD
Lovastatin—SLCO1A2—telencephalon—germ cell cancer	0.000631	0.00593	CbGeAlD
Lovastatin—HDAC2—female gonad—germ cell cancer	0.000608	0.00572	CbGeAlD
Lovastatin—HMGCR—adrenal gland—germ cell cancer	0.000589	0.00554	CbGeAlD
Lovastatin—UGT1A1—endocrine gland—germ cell cancer	0.000588	0.00553	CbGeAlD
Lovastatin—Ill-defined disorder—Vinblastine—germ cell cancer	0.000583	0.00526	CcSEcCtD
Lovastatin—UGT2B7—Metapathway biotransformation—NAT9—germ cell cancer	0.000583	0.0349	CbGpPWpGaD
Lovastatin—SLCO1A2—Transport of organic anions—AVP—germ cell cancer	0.000581	0.0348	CbGpPWpGaD
Lovastatin—HMGCR—midbrain—germ cell cancer	0.000581	0.00547	CbGeAlD
Lovastatin—Stevens-Johnson syndrome—Ifosfamide—germ cell cancer	0.000575	0.00519	CcSEcCtD
Lovastatin—ABCB1—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.000574	0.0343	CbGpPWpGaD
Lovastatin—HMGCR—bone marrow—germ cell cancer	0.00057	0.00535	CbGeAlD
Lovastatin—Neuropathy peripheral—Ifosfamide—germ cell cancer	0.000569	0.00514	CcSEcCtD
Lovastatin—Hepatitis—Dactinomycin—germ cell cancer	0.000568	0.00513	CcSEcCtD
Lovastatin—HMGCR—spinal cord—germ cell cancer	0.000567	0.00533	CbGeAlD
Lovastatin—Malaise—Vinblastine—germ cell cancer	0.000566	0.00512	CcSEcCtD
Lovastatin—HDAC2—endocrine gland—germ cell cancer	0.000566	0.00532	CbGeAlD
Lovastatin—Flushing—Bleomycin—germ cell cancer	0.000565	0.00511	CcSEcCtD
Lovastatin—Vertigo—Vinblastine—germ cell cancer	0.000564	0.0051	CcSEcCtD
Lovastatin—Leukopenia—Vinblastine—germ cell cancer	0.000562	0.00508	CcSEcCtD
Lovastatin—HDAC2—head—germ cell cancer	0.000559	0.00525	CbGeAlD
Lovastatin—Pancreatitis—Cisplatin—germ cell cancer	0.00055	0.00497	CcSEcCtD
Lovastatin—HMGCR—female gonad—germ cell cancer	0.000549	0.00516	CbGeAlD
Lovastatin—Chills—Bleomycin—germ cell cancer	0.000547	0.00494	CcSEcCtD
Lovastatin—HDAC2—testis—germ cell cancer	0.00054	0.00507	CbGeAlD
Lovastatin—Alopecia—Bleomycin—germ cell cancer	0.000538	0.00486	CcSEcCtD
Lovastatin—Abdominal discomfort—Cisplatin—germ cell cancer	0.000538	0.00486	CcSEcCtD
Lovastatin—Erythema multiforme—Dactinomycin—germ cell cancer	0.000537	0.00485	CcSEcCtD
Lovastatin—Cramp muscle—Etoposide—germ cell cancer	0.000535	0.00484	CcSEcCtD
Lovastatin—Toxic epidermal necrolysis—Etoposide—germ cell cancer	0.000535	0.00484	CcSEcCtD
Lovastatin—Discomfort—Vinblastine—germ cell cancer	0.000528	0.00477	CcSEcCtD
Lovastatin—Flushing—Dactinomycin—germ cell cancer	0.000527	0.00476	CcSEcCtD
Lovastatin—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—SALL4—germ cell cancer	0.000522	0.0312	CbGpPWpGaD
Lovastatin—Hepatitis—Ifosfamide—germ cell cancer	0.000521	0.0047	CcSEcCtD
Lovastatin—HMGCR—endocrine gland—germ cell cancer	0.000511	0.0048	CbGeAlD
Lovastatin—Chills—Dactinomycin—germ cell cancer	0.00051	0.00461	CcSEcCtD
Lovastatin—HMGCR—head—germ cell cancer	0.000504	0.00474	CbGeAlD
Lovastatin—Vasculitis—Methotrexate—germ cell cancer	0.000503	0.00454	CcSEcCtD
Lovastatin—Alopecia—Dactinomycin—germ cell cancer	0.000502	0.00454	CcSEcCtD
Lovastatin—Thrombocytopenia—Vinblastine—germ cell cancer	0.000502	0.00453	CcSEcCtD
Lovastatin—HDAC2—cerebellum—germ cell cancer	0.000498	0.00469	CbGeAlD
Lovastatin—SLCO1B1—Transport of organic anions—AVP—germ cell cancer	0.000497	0.0298	CbGpPWpGaD
Lovastatin—SLCO1A2—medulla oblongata—germ cell cancer	0.000496	0.00466	CbGeAlD
Lovastatin—Erythema multiforme—Ifosfamide—germ cell cancer	0.000492	0.00445	CcSEcCtD
Lovastatin—Ill-defined disorder—Bleomycin—germ cell cancer	0.000492	0.00444	CcSEcCtD
Lovastatin—Neuropathy peripheral—Cisplatin—germ cell cancer	0.00049	0.00443	CcSEcCtD
Lovastatin—SLCO1B1—endocrine gland—germ cell cancer	0.000489	0.0046	CbGeAlD
Lovastatin—Anorexia—Vinblastine—germ cell cancer	0.000489	0.00441	CcSEcCtD
Lovastatin—HMGCR—testis—germ cell cancer	0.000487	0.00458	CbGeAlD
Lovastatin—Flushing—Ifosfamide—germ cell cancer	0.000483	0.00437	CcSEcCtD
Lovastatin—Malaise—Bleomycin—germ cell cancer	0.000478	0.00432	CcSEcCtD
Lovastatin—Leukopenia—Bleomycin—germ cell cancer	0.000475	0.00429	CcSEcCtD
Lovastatin—UGT1A1—Metapathway biotransformation—NAT9—germ cell cancer	0.000473	0.0283	CbGpPWpGaD
Lovastatin—Chills—Ifosfamide—germ cell cancer	0.000467	0.00422	CcSEcCtD
Lovastatin—Paraesthesia—Vinblastine—germ cell cancer	0.00046	0.00416	CcSEcCtD
Lovastatin—Alopecia—Ifosfamide—germ cell cancer	0.00046	0.00416	CcSEcCtD
Lovastatin—Ill-defined disorder—Dactinomycin—germ cell cancer	0.000459	0.00415	CcSEcCtD
Lovastatin—Stevens-Johnson syndrome—Etoposide—germ cell cancer	0.000454	0.0041	CcSEcCtD
Lovastatin—SLCO1A2—midbrain—germ cell cancer	0.000453	0.00426	CbGeAlD
Lovastatin—Chest pain—Bleomycin—germ cell cancer	0.000452	0.00408	CcSEcCtD
Lovastatin—Myalgia—Bleomycin—germ cell cancer	0.000452	0.00408	CcSEcCtD
Lovastatin—HMGCR—cerebellum—germ cell cancer	0.00045	0.00423	CbGeAlD
Lovastatin—Neuropathy peripheral—Etoposide—germ cell cancer	0.000449	0.00406	CcSEcCtD
Lovastatin—Discomfort—Bleomycin—germ cell cancer	0.000446	0.00403	CcSEcCtD
Lovastatin—Malaise—Dactinomycin—germ cell cancer	0.000446	0.00403	CcSEcCtD
Lovastatin—Decreased appetite—Vinblastine—germ cell cancer	0.000446	0.00402	CcSEcCtD
Lovastatin—Leukopenia—Dactinomycin—germ cell cancer	0.000443	0.004	CcSEcCtD
Lovastatin—SLCO1A2—spinal cord—germ cell cancer	0.000442	0.00416	CbGeAlD
Lovastatin—Gynaecomastia—Methotrexate—germ cell cancer	0.000439	0.00396	CcSEcCtD
Lovastatin—Pain—Vinblastine—germ cell cancer	0.000438	0.00396	CcSEcCtD
Lovastatin—Constipation—Vinblastine—germ cell cancer	0.000438	0.00396	CcSEcCtD
Lovastatin—Confusional state—Bleomycin—germ cell cancer	0.000436	0.00394	CcSEcCtD
Lovastatin—ABCB1—blood vessel—germ cell cancer	0.000436	0.0041	CbGeAlD
Lovastatin—Anaphylactic shock—Bleomycin—germ cell cancer	0.000433	0.00391	CcSEcCtD
Lovastatin—Infection—Bleomycin—germ cell cancer	0.00043	0.00388	CcSEcCtD
Lovastatin—ABCC2—adrenal gland—germ cell cancer	0.000428	0.00402	CbGeAlD
Lovastatin—Vision blurred—Ifosfamide—germ cell cancer	0.000427	0.00386	CcSEcCtD
Lovastatin—Thrombocytopenia—Bleomycin—germ cell cancer	0.000424	0.00383	CcSEcCtD
Lovastatin—Feeling abnormal—Vinblastine—germ cell cancer	0.000422	0.00381	CcSEcCtD
Lovastatin—Myalgia—Dactinomycin—germ cell cancer	0.000421	0.0038	CcSEcCtD
Lovastatin—Ill-defined disorder—Ifosfamide—germ cell cancer	0.000421	0.0038	CcSEcCtD
Lovastatin—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000419	0.00379	CcSEcCtD
Lovastatin—Flushing—Cisplatin—germ cell cancer	0.000417	0.00376	CcSEcCtD
Lovastatin—Discomfort—Dactinomycin—germ cell cancer	0.000416	0.00376	CcSEcCtD
Lovastatin—Angioedema—Ifosfamide—germ cell cancer	0.000414	0.00374	CcSEcCtD
Lovastatin—Anorexia—Bleomycin—germ cell cancer	0.000413	0.00373	CcSEcCtD
Lovastatin—Malaise—Ifosfamide—germ cell cancer	0.000409	0.00369	CcSEcCtD
Lovastatin—Vertigo—Ifosfamide—germ cell cancer	0.000407	0.00368	CcSEcCtD
Lovastatin—Leukopenia—Ifosfamide—germ cell cancer	0.000406	0.00366	CcSEcCtD
Lovastatin—Photosensitivity—Methotrexate—germ cell cancer	0.000406	0.00366	CcSEcCtD
Lovastatin—Abdominal pain—Vinblastine—germ cell cancer	0.000405	0.00366	CcSEcCtD
Lovastatin—HDAC2—brain—germ cell cancer	0.000405	0.00381	CbGeAlD
Lovastatin—Infection—Dactinomycin—germ cell cancer	0.000401	0.00362	CcSEcCtD
Lovastatin—CYP3A7—Metapathway biotransformation—NAT9—germ cell cancer	0.000398	0.0238	CbGpPWpGaD
Lovastatin—SLCO1A2—endocrine gland—germ cell cancer	0.000398	0.00374	CbGeAlD
Lovastatin—Alopecia—Cisplatin—germ cell cancer	0.000397	0.00358	CcSEcCtD
Lovastatin—Hepatic failure—Methotrexate—germ cell cancer	0.000396	0.00358	CcSEcCtD
Lovastatin—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000395	0.00357	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000394	0.00356	CcSEcCtD
Lovastatin—SLCO1A2—head—germ cell cancer	0.000393	0.00369	CbGeAlD
Lovastatin—HDAC2—lymph node—germ cell cancer	0.000391	0.00368	CbGeAlD
Lovastatin—Erythema multiforme—Etoposide—germ cell cancer	0.000389	0.00351	CcSEcCtD
Lovastatin—Paraesthesia—Bleomycin—germ cell cancer	0.000389	0.00351	CcSEcCtD
Lovastatin—Dyspnoea—Bleomycin—germ cell cancer	0.000386	0.00349	CcSEcCtD
Lovastatin—Chest pain—Ifosfamide—germ cell cancer	0.000386	0.00349	CcSEcCtD
Lovastatin—Myalgia—Ifosfamide—germ cell cancer	0.000386	0.00349	CcSEcCtD
Lovastatin—Arthralgia—Ifosfamide—germ cell cancer	0.000386	0.00349	CcSEcCtD
Lovastatin—Flatulence—Cisplatin—germ cell cancer	0.000385	0.00348	CcSEcCtD
Lovastatin—Anorexia—Dactinomycin—germ cell cancer	0.000385	0.00348	CcSEcCtD
Lovastatin—Flushing—Etoposide—germ cell cancer	0.000382	0.00345	CcSEcCtD
Lovastatin—Discomfort—Ifosfamide—germ cell cancer	0.000381	0.00344	CcSEcCtD
Lovastatin—SLCO1A2—testis—germ cell cancer	0.00038	0.00357	CbGeAlD
Lovastatin—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—KLF4—germ cell cancer	0.000379	0.0227	CbGpPWpGaD
Lovastatin—Hypersensitivity—Vinblastine—germ cell cancer	0.000378	0.00341	CcSEcCtD
Lovastatin—Decreased appetite—Bleomycin—germ cell cancer	0.000376	0.0034	CcSEcCtD
Lovastatin—Muscle spasms—Cisplatin—germ cell cancer	0.000376	0.00339	CcSEcCtD
Lovastatin—Confusional state—Ifosfamide—germ cell cancer	0.000373	0.00337	CcSEcCtD
Lovastatin—ABCC2—endocrine gland—germ cell cancer	0.000371	0.00349	CbGeAlD
Lovastatin—Pain—Bleomycin—germ cell cancer	0.00037	0.00334	CcSEcCtD
Lovastatin—Anaphylactic shock—Ifosfamide—germ cell cancer	0.00037	0.00334	CcSEcCtD
Lovastatin—Chills—Etoposide—germ cell cancer	0.000369	0.00333	CcSEcCtD
Lovastatin—Vision blurred—Cisplatin—germ cell cancer	0.000368	0.00333	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000368	0.00332	CcSEcCtD
Lovastatin—Asthenia—Vinblastine—germ cell cancer	0.000368	0.00332	CcSEcCtD
Lovastatin—Infection—Ifosfamide—germ cell cancer	0.000368	0.00332	CcSEcCtD
Lovastatin—Tremor—Cisplatin—germ cell cancer	0.000366	0.00331	CcSEcCtD
Lovastatin—HMGCR—brain—germ cell cancer	0.000365	0.00343	CbGeAlD
Lovastatin—Alopecia—Etoposide—germ cell cancer	0.000363	0.00328	CcSEcCtD
Lovastatin—Ill-defined disorder—Cisplatin—germ cell cancer	0.000363	0.00328	CcSEcCtD
Lovastatin—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000362	0.00327	CcSEcCtD
Lovastatin—CYP2C8—pituitary gland—germ cell cancer	0.000359	0.00338	CbGeAlD
Lovastatin—HDAC2—Epigenetic regulation of gene expression—DNMT3L—germ cell cancer	0.000357	0.0214	CbGpPWpGaD
Lovastatin—Feeling abnormal—Bleomycin—germ cell cancer	0.000357	0.00322	CcSEcCtD
Lovastatin—ABCC2—testis—germ cell cancer	0.000354	0.00332	CbGeAlD
Lovastatin—HMGCR—lymph node—germ cell cancer	0.000353	0.00332	CbGeAlD
Lovastatin—Anorexia—Ifosfamide—germ cell cancer	0.000353	0.00319	CcSEcCtD
Lovastatin—Malaise—Cisplatin—germ cell cancer	0.000352	0.00318	CcSEcCtD
Lovastatin—Decreased appetite—Dactinomycin—germ cell cancer	0.000351	0.00317	CcSEcCtD
Lovastatin—Diarrhoea—Vinblastine—germ cell cancer	0.000351	0.00317	CcSEcCtD
Lovastatin—SLCO1A2—cerebellum—germ cell cancer	0.000351	0.0033	CbGeAlD
Lovastatin—Dysgeusia—Etoposide—germ cell cancer	0.000351	0.00317	CcSEcCtD
Lovastatin—Leukopenia—Cisplatin—germ cell cancer	0.00035	0.00316	CcSEcCtD
Lovastatin—Fatigue—Dactinomycin—germ cell cancer	0.000348	0.00314	CcSEcCtD
Lovastatin—Back pain—Etoposide—germ cell cancer	0.000346	0.00313	CcSEcCtD
Lovastatin—Pain—Dactinomycin—germ cell cancer	0.000345	0.00312	CcSEcCtD
Lovastatin—Muscle spasms—Etoposide—germ cell cancer	0.000344	0.00311	CcSEcCtD
Lovastatin—Urticaria—Bleomycin—germ cell cancer	0.000344	0.00311	CcSEcCtD
Lovastatin—Body temperature increased—Bleomycin—germ cell cancer	0.000342	0.00309	CcSEcCtD
Lovastatin—Dizziness—Vinblastine—germ cell cancer	0.000339	0.00306	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000337	0.00304	CcSEcCtD
Lovastatin—Myalgia—Cisplatin—germ cell cancer	0.000333	0.00301	CcSEcCtD
Lovastatin—Feeling abnormal—Dactinomycin—germ cell cancer	0.000333	0.003	CcSEcCtD
Lovastatin—Paraesthesia—Ifosfamide—germ cell cancer	0.000332	0.003	CcSEcCtD
Lovastatin—Ill-defined disorder—Etoposide—germ cell cancer	0.000332	0.003	CcSEcCtD
Lovastatin—Anxiety—Cisplatin—germ cell cancer	0.000332	0.00299	CcSEcCtD
Lovastatin—CYP2D6—brainstem—germ cell cancer	0.000331	0.00311	CbGeAlD
Lovastatin—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.00033	0.00298	CcSEcCtD
Lovastatin—Dyspnoea—Ifosfamide—germ cell cancer	0.00033	0.00298	CcSEcCtD
Lovastatin—Discomfort—Cisplatin—germ cell cancer	0.000329	0.00297	CcSEcCtD
Lovastatin—Vomiting—Vinblastine—germ cell cancer	0.000326	0.00294	CcSEcCtD
Lovastatin—Malaise—Etoposide—germ cell cancer	0.000323	0.00292	CcSEcCtD
Lovastatin—Vertigo—Etoposide—germ cell cancer	0.000322	0.00291	CcSEcCtD
Lovastatin—Decreased appetite—Ifosfamide—germ cell cancer	0.000322	0.0029	CcSEcCtD
Lovastatin—Headache—Vinblastine—germ cell cancer	0.000321	0.0029	CcSEcCtD
Lovastatin—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.000321	0.0029	CcSEcCtD
Lovastatin—Leukopenia—Etoposide—germ cell cancer	0.00032	0.00289	CcSEcCtD
Lovastatin—Abdominal pain—Dactinomycin—germ cell cancer	0.000319	0.00288	CcSEcCtD
Lovastatin—Body temperature increased—Dactinomycin—germ cell cancer	0.000319	0.00288	CcSEcCtD
Lovastatin—Fatigue—Ifosfamide—germ cell cancer	0.000319	0.00288	CcSEcCtD
Lovastatin—Anaphylactic shock—Cisplatin—germ cell cancer	0.000319	0.00288	CcSEcCtD
Lovastatin—Hypersensitivity—Bleomycin—germ cell cancer	0.000319	0.00288	CcSEcCtD
Lovastatin—CYP2C19—endocrine gland—germ cell cancer	0.000319	0.003	CbGeAlD
Lovastatin—Infection—Cisplatin—germ cell cancer	0.000317	0.00286	CcSEcCtD
Lovastatin—Constipation—Ifosfamide—germ cell cancer	0.000316	0.00286	CcSEcCtD
Lovastatin—Pain—Ifosfamide—germ cell cancer	0.000316	0.00286	CcSEcCtD
Lovastatin—Thrombocytopenia—Cisplatin—germ cell cancer	0.000312	0.00282	CcSEcCtD
Lovastatin—Asthenia—Bleomycin—germ cell cancer	0.000311	0.00281	CcSEcCtD
Lovastatin—Pruritus—Bleomycin—germ cell cancer	0.000306	0.00277	CcSEcCtD
Lovastatin—Feeling abnormal—Ifosfamide—germ cell cancer	0.000305	0.00275	CcSEcCtD
Lovastatin—Chest pain—Etoposide—germ cell cancer	0.000305	0.00275	CcSEcCtD
Lovastatin—Eosinophilia—Methotrexate—germ cell cancer	0.000305	0.00275	CcSEcCtD
Lovastatin—Nausea—Vinblastine—germ cell cancer	0.000304	0.00275	CcSEcCtD
Lovastatin—Anorexia—Cisplatin—germ cell cancer	0.000304	0.00275	CcSEcCtD
Lovastatin—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000303	0.00273	CcSEcCtD
Lovastatin—Pancreatitis—Methotrexate—germ cell cancer	0.000302	0.00273	CcSEcCtD
Lovastatin—Discomfort—Etoposide—germ cell cancer	0.000301	0.00272	CcSEcCtD
Lovastatin—Hypersensitivity—Dactinomycin—germ cell cancer	0.000297	0.00269	CcSEcCtD
Lovastatin—Abdominal discomfort—Methotrexate—germ cell cancer	0.000295	0.00266	CcSEcCtD
Lovastatin—Confusional state—Etoposide—germ cell cancer	0.000295	0.00266	CcSEcCtD
Lovastatin—CYP2D6—telencephalon—germ cell cancer	0.000294	0.00276	CbGeAlD
Lovastatin—Urticaria—Ifosfamide—germ cell cancer	0.000294	0.00265	CcSEcCtD
Lovastatin—Body temperature increased—Ifosfamide—germ cell cancer	0.000292	0.00264	CcSEcCtD
Lovastatin—Abdominal pain—Ifosfamide—germ cell cancer	0.000292	0.00264	CcSEcCtD
Lovastatin—Anaphylactic shock—Etoposide—germ cell cancer	0.000292	0.00264	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000291	0.00262	CcSEcCtD
Lovastatin—Infection—Etoposide—germ cell cancer	0.00029	0.00262	CcSEcCtD
Lovastatin—Asthenia—Dactinomycin—germ cell cancer	0.00029	0.00262	CcSEcCtD
Lovastatin—CYP3A5—Metapathway biotransformation—NAT9—germ cell cancer	0.000288	0.0172	CbGpPWpGaD
Lovastatin—Paraesthesia—Cisplatin—germ cell cancer	0.000286	0.00259	CcSEcCtD
Lovastatin—Thrombocytopenia—Etoposide—germ cell cancer	0.000286	0.00258	CcSEcCtD
Lovastatin—SLCO1A2—brain—germ cell cancer	0.000285	0.00268	CbGeAlD
Lovastatin—Dyspnoea—Cisplatin—germ cell cancer	0.000284	0.00257	CcSEcCtD
Lovastatin—Erectile dysfunction—Methotrexate—germ cell cancer	0.000283	0.00256	CcSEcCtD
Lovastatin—Photosensitivity reaction—Methotrexate—germ cell cancer	0.000281	0.00254	CcSEcCtD
Lovastatin—Anorexia—Etoposide—germ cell cancer	0.000279	0.00252	CcSEcCtD
Lovastatin—CYP2C8—endocrine gland—germ cell cancer	0.000278	0.00261	CbGeAlD
Lovastatin—Decreased appetite—Cisplatin—germ cell cancer	0.000277	0.0025	CcSEcCtD
Lovastatin—Diarrhoea—Dactinomycin—germ cell cancer	0.000276	0.00249	CcSEcCtD
Lovastatin—Vomiting—Bleomycin—germ cell cancer	0.000275	0.00249	CcSEcCtD
Lovastatin—Rash—Bleomycin—germ cell cancer	0.000273	0.00247	CcSEcCtD
Lovastatin—Pain—Cisplatin—germ cell cancer	0.000273	0.00246	CcSEcCtD
Lovastatin—Dermatitis—Bleomycin—germ cell cancer	0.000273	0.00246	CcSEcCtD
Lovastatin—Hypersensitivity—Ifosfamide—germ cell cancer	0.000273	0.00246	CcSEcCtD
Lovastatin—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.000272	0.00246	CcSEcCtD
Lovastatin—CYP3A5—female gonad—germ cell cancer	0.00027	0.00254	CbGeAlD
Lovastatin—ABCB1—trigeminal ganglion—germ cell cancer	0.000269	0.00253	CbGeAlD
Lovastatin—Asthenia—Ifosfamide—germ cell cancer	0.000265	0.0024	CcSEcCtD
Lovastatin—CYP2C8—testis—germ cell cancer	0.000265	0.00249	CbGeAlD
Lovastatin—Feeling abnormal—Cisplatin—germ cell cancer	0.000263	0.00237	CcSEcCtD
Lovastatin—Paraesthesia—Etoposide—germ cell cancer	0.000262	0.00237	CcSEcCtD
Lovastatin—Pruritus—Ifosfamide—germ cell cancer	0.000262	0.00236	CcSEcCtD
Lovastatin—Dyspnoea—Etoposide—germ cell cancer	0.000261	0.00235	CcSEcCtD
Lovastatin—ABCB1—embryo—germ cell cancer	0.00026	0.00244	CbGeAlD
Lovastatin—Nausea—Bleomycin—germ cell cancer	0.000257	0.00232	CcSEcCtD
Lovastatin—Vomiting—Dactinomycin—germ cell cancer	0.000257	0.00232	CcSEcCtD
Lovastatin—ABCC2—lymph node—germ cell cancer	0.000256	0.00241	CbGeAlD
Lovastatin—Rash—Dactinomycin—germ cell cancer	0.000255	0.0023	CcSEcCtD
Lovastatin—Decreased appetite—Etoposide—germ cell cancer	0.000254	0.00229	CcSEcCtD
Lovastatin—Diarrhoea—Ifosfamide—germ cell cancer	0.000253	0.00229	CcSEcCtD
Lovastatin—Body temperature increased—Cisplatin—germ cell cancer	0.000252	0.00228	CcSEcCtD
Lovastatin—Fatigue—Etoposide—germ cell cancer	0.000252	0.00228	CcSEcCtD
Lovastatin—CYP3A5—endocrine gland—germ cell cancer	0.000251	0.00236	CbGeAlD
Lovastatin—Constipation—Etoposide—germ cell cancer	0.00025	0.00226	CcSEcCtD
Lovastatin—Pain—Etoposide—germ cell cancer	0.00025	0.00226	CcSEcCtD
Lovastatin—CYP2C8—Metapathway biotransformation—NAT9—germ cell cancer	0.000249	0.0149	CbGpPWpGaD
Lovastatin—CYP2C9—endocrine gland—germ cell cancer	0.000247	0.00232	CbGeAlD
Lovastatin—ITGAL—Hemostasis—CD9—germ cell cancer	0.000247	0.0148	CbGpPWpGaD
Lovastatin—Hepatitis—Methotrexate—germ cell cancer	0.000246	0.00223	CcSEcCtD
Lovastatin—Dizziness—Ifosfamide—germ cell cancer	0.000245	0.00221	CcSEcCtD
Lovastatin—Feeling abnormal—Etoposide—germ cell cancer	0.000241	0.00217	CcSEcCtD
Lovastatin—Nausea—Dactinomycin—germ cell cancer	0.00024	0.00217	CcSEcCtD
Lovastatin—Gastrointestinal pain—Etoposide—germ cell cancer	0.000239	0.00216	CcSEcCtD
Lovastatin—Vomiting—Ifosfamide—germ cell cancer	0.000235	0.00212	CcSEcCtD
Lovastatin—Hypersensitivity—Cisplatin—germ cell cancer	0.000235	0.00212	CcSEcCtD
Lovastatin—Rash—Ifosfamide—germ cell cancer	0.000233	0.00211	CcSEcCtD
Lovastatin—Dermatitis—Ifosfamide—germ cell cancer	0.000233	0.0021	CcSEcCtD
Lovastatin—Erythema multiforme—Methotrexate—germ cell cancer	0.000233	0.0021	CcSEcCtD
Lovastatin—Urticaria—Etoposide—germ cell cancer	0.000232	0.0021	CcSEcCtD
Lovastatin—Body temperature increased—Etoposide—germ cell cancer	0.000231	0.00209	CcSEcCtD
Lovastatin—Abdominal pain—Etoposide—germ cell cancer	0.000231	0.00209	CcSEcCtD
Lovastatin—ABCB1—retina—germ cell cancer	0.00023	0.00216	CbGeAlD
Lovastatin—Asthenia—Cisplatin—germ cell cancer	0.000229	0.00207	CcSEcCtD
Lovastatin—CYP2C19—Metapathway biotransformation—NAT9—germ cell cancer	0.000222	0.0133	CbGpPWpGaD
Lovastatin—Chills—Methotrexate—germ cell cancer	0.000221	0.002	CcSEcCtD
Lovastatin—Nausea—Ifosfamide—germ cell cancer	0.00022	0.00198	CcSEcCtD
Lovastatin—Diarrhoea—Cisplatin—germ cell cancer	0.000218	0.00197	CcSEcCtD
Lovastatin—Alopecia—Methotrexate—germ cell cancer	0.000218	0.00197	CcSEcCtD
Lovastatin—SLCO1A2—Transport of vitamins, nucleosides, and related molecules—AVP—germ cell cancer	0.000216	0.0129	CbGpPWpGaD
Lovastatin—Hypersensitivity—Etoposide—germ cell cancer	0.000215	0.00194	CcSEcCtD
Lovastatin—UGT1A3—NRF2 pathway—SLC2A3—germ cell cancer	0.000215	0.0129	CbGpPWpGaD
Lovastatin—ABCB1—telencephalon—germ cell cancer	0.000211	0.00199	CbGeAlD
Lovastatin—Dysgeusia—Methotrexate—germ cell cancer	0.00021	0.0019	CcSEcCtD
Lovastatin—Asthenia—Etoposide—germ cell cancer	0.00021	0.00189	CcSEcCtD
Lovastatin—Back pain—Methotrexate—germ cell cancer	0.000207	0.00187	CcSEcCtD
Lovastatin—Pruritus—Etoposide—germ cell cancer	0.000207	0.00187	CcSEcCtD
Lovastatin—CYP2D6—Metapathway biotransformation—NAT9—germ cell cancer	0.000205	0.0123	CbGpPWpGaD
Lovastatin—CYP2C9—Metapathway biotransformation—NAT9—germ cell cancer	0.000203	0.0121	CbGpPWpGaD
Lovastatin—Vomiting—Cisplatin—germ cell cancer	0.000203	0.00183	CcSEcCtD
Lovastatin—Vision blurred—Methotrexate—germ cell cancer	0.000202	0.00183	CcSEcCtD
Lovastatin—Rash—Cisplatin—germ cell cancer	0.000201	0.00182	CcSEcCtD
Lovastatin—Dermatitis—Cisplatin—germ cell cancer	0.000201	0.00181	CcSEcCtD
Lovastatin—ABCB1—decidua—germ cell cancer	0.0002	0.00188	CbGeAlD
Lovastatin—Diarrhoea—Etoposide—germ cell cancer	0.0002	0.00181	CcSEcCtD
Lovastatin—ITGAL—Adaptive Immune System—PVRL2—germ cell cancer	0.0002	0.0119	CbGpPWpGaD
Lovastatin—CYP2D6—female gonad—germ cell cancer	0.000199	0.00187	CbGeAlD
Lovastatin—CYP2C8—brain—germ cell cancer	0.000199	0.00187	CbGeAlD
Lovastatin—Ill-defined disorder—Methotrexate—germ cell cancer	0.000199	0.0018	CcSEcCtD
Lovastatin—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—FGF4—germ cell cancer	0.000196	0.0117	CbGpPWpGaD
Lovastatin—Malaise—Methotrexate—germ cell cancer	0.000193	0.00175	CcSEcCtD
Lovastatin—Dizziness—Etoposide—germ cell cancer	0.000193	0.00175	CcSEcCtD
Lovastatin—Vertigo—Methotrexate—germ cell cancer	0.000193	0.00174	CcSEcCtD
Lovastatin—Leukopenia—Methotrexate—germ cell cancer	0.000192	0.00173	CcSEcCtD
Lovastatin—Nausea—Cisplatin—germ cell cancer	0.000189	0.00171	CcSEcCtD
Lovastatin—CYP3A4—endocrine gland—germ cell cancer	0.000188	0.00177	CbGeAlD
Lovastatin—Vomiting—Etoposide—germ cell cancer	0.000186	0.00168	CcSEcCtD
Lovastatin—CYP2D6—endocrine gland—germ cell cancer	0.000185	0.00174	CbGeAlD
Lovastatin—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—AVP—germ cell cancer	0.000184	0.011	CbGpPWpGaD
Lovastatin—Rash—Etoposide—germ cell cancer	0.000184	0.00166	CcSEcCtD
Lovastatin—Dermatitis—Etoposide—germ cell cancer	0.000184	0.00166	CcSEcCtD
Lovastatin—Headache—Etoposide—germ cell cancer	0.000183	0.00165	CcSEcCtD
Lovastatin—CYP2D6—head—germ cell cancer	0.000183	0.00172	CbGeAlD
Lovastatin—UGT2B7—NRF2 pathway—SLC2A3—germ cell cancer	0.000183	0.011	CbGpPWpGaD
Lovastatin—Arthralgia—Methotrexate—germ cell cancer	0.000183	0.00165	CcSEcCtD
Lovastatin—Chest pain—Methotrexate—germ cell cancer	0.000183	0.00165	CcSEcCtD
Lovastatin—Myalgia—Methotrexate—germ cell cancer	0.000183	0.00165	CcSEcCtD
Lovastatin—Discomfort—Methotrexate—germ cell cancer	0.00018	0.00163	CcSEcCtD
Lovastatin—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—germ cell cancer	0.000179	0.0107	CbGpPWpGaD
Lovastatin—CYP2D6—testis—germ cell cancer	0.000177	0.00166	CbGeAlD
Lovastatin—Confusional state—Methotrexate—germ cell cancer	0.000176	0.00159	CcSEcCtD
Lovastatin—ABCB1—gonad—germ cell cancer	0.000176	0.00166	CbGeAlD
Lovastatin—ABCB1—uterus—germ cell cancer	0.000175	0.00165	CbGeAlD
Lovastatin—Anaphylactic shock—Methotrexate—germ cell cancer	0.000175	0.00158	CcSEcCtD
Lovastatin—Infection—Methotrexate—germ cell cancer	0.000174	0.00157	CcSEcCtD
Lovastatin—Nausea—Etoposide—germ cell cancer	0.000174	0.00157	CcSEcCtD
Lovastatin—ABCB1—pituitary gland—germ cell cancer	0.000172	0.00162	CbGeAlD
Lovastatin—Thrombocytopenia—Methotrexate—germ cell cancer	0.000171	0.00155	CcSEcCtD
Lovastatin—Anorexia—Methotrexate—germ cell cancer	0.000167	0.00151	CcSEcCtD
Lovastatin—ABCB1—medulla oblongata—germ cell cancer	0.000166	0.00156	CbGeAlD
Lovastatin—CYP2D6—cerebellum—germ cell cancer	0.000163	0.00153	CbGeAlD
Lovastatin—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000159	0.00144	CcSEcCtD
Lovastatin—Insomnia—Methotrexate—germ cell cancer	0.000158	0.00143	CcSEcCtD
Lovastatin—Paraesthesia—Methotrexate—germ cell cancer	0.000157	0.00142	CcSEcCtD
Lovastatin—Dyspnoea—Methotrexate—germ cell cancer	0.000156	0.00141	CcSEcCtD
Lovastatin—Dyspepsia—Methotrexate—germ cell cancer	0.000154	0.00139	CcSEcCtD
Lovastatin—ABCB1—adrenal gland—germ cell cancer	0.000154	0.00145	CbGeAlD
Lovastatin—Decreased appetite—Methotrexate—germ cell cancer	0.000152	0.00137	CcSEcCtD
Lovastatin—ABCB1—midbrain—germ cell cancer	0.000152	0.00143	CbGeAlD
Lovastatin—Fatigue—Methotrexate—germ cell cancer	0.000151	0.00136	CcSEcCtD
Lovastatin—Pain—Methotrexate—germ cell cancer	0.00015	0.00135	CcSEcCtD
Lovastatin—ABCB1—bone marrow—germ cell cancer	0.000149	0.0014	CbGeAlD
Lovastatin—UGT1A1—NRF2 pathway—SLC2A3—germ cell cancer	0.000149	0.0089	CbGpPWpGaD
Lovastatin—ABCB1—spinal cord—germ cell cancer	0.000148	0.00139	CbGeAlD
Lovastatin—ABCC2—NRF2 pathway—SLC2A3—germ cell cancer	0.000145	0.00868	CbGpPWpGaD
Lovastatin—Feeling abnormal—Methotrexate—germ cell cancer	0.000144	0.0013	CcSEcCtD
Lovastatin—HDAC2—NoRC negatively regulates rRNA expression—H2AFZ—germ cell cancer	0.000144	0.00863	CbGpPWpGaD
Lovastatin—ABCB1—female gonad—germ cell cancer	0.000143	0.00135	CbGeAlD
Lovastatin—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000143	0.00129	CcSEcCtD
Lovastatin—HDAC2—Negative epigenetic regulation of rRNA expression—H2AFZ—germ cell cancer	0.000141	0.00843	CbGpPWpGaD
Lovastatin—HDAC2—RNA Polymerase I Promoter Clearance—H2AFZ—germ cell cancer	0.000141	0.00843	CbGpPWpGaD
Lovastatin—Urticaria—Methotrexate—germ cell cancer	0.000139	0.00126	CcSEcCtD
Lovastatin—HDAC2—RNA Polymerase I Transcription—H2AFZ—germ cell cancer	0.000139	0.00831	CbGpPWpGaD
Lovastatin—Abdominal pain—Methotrexate—germ cell cancer	0.000138	0.00125	CcSEcCtD
Lovastatin—Body temperature increased—Methotrexate—germ cell cancer	0.000138	0.00125	CcSEcCtD
Lovastatin—CYP3A4—Metapathway biotransformation—NAT9—germ cell cancer	0.000134	0.00801	CbGpPWpGaD
Lovastatin—ABCB1—endocrine gland—germ cell cancer	0.000133	0.00125	CbGeAlD
Lovastatin—HDAC2—Cell Cycle—KITLG—germ cell cancer	0.000133	0.00794	CbGpPWpGaD
Lovastatin—CYP2D6—brain—germ cell cancer	0.000133	0.00125	CbGeAlD
Lovastatin—ABCB1—head—germ cell cancer	0.000132	0.00124	CbGeAlD
Lovastatin—ITGAL—Cell surface interactions at the vascular wall—HRAS—germ cell cancer	0.00013	0.0078	CbGpPWpGaD
Lovastatin—ITGAL—Integrin-mediated Cell Adhesion—HRAS—germ cell cancer	0.000129	0.00774	CbGpPWpGaD
Lovastatin—Hypersensitivity—Methotrexate—germ cell cancer	0.000129	0.00116	CcSEcCtD
Lovastatin—ABCB1—testis—germ cell cancer	0.000127	0.0012	CbGeAlD
Lovastatin—ITGAL—Adaptive Immune System—FGF4—germ cell cancer	0.000126	0.00755	CbGpPWpGaD
Lovastatin—Asthenia—Methotrexate—germ cell cancer	0.000126	0.00113	CcSEcCtD
Lovastatin—HDAC2—Epigenetic regulation of gene expression—H2AFZ—germ cell cancer	0.000125	0.00748	CbGpPWpGaD
Lovastatin—Pruritus—Methotrexate—germ cell cancer	0.000124	0.00112	CcSEcCtD
Lovastatin—ITGAL—Immune System—PVRL2—germ cell cancer	0.000121	0.00725	CbGpPWpGaD
Lovastatin—Diarrhoea—Methotrexate—germ cell cancer	0.00012	0.00108	CcSEcCtD
Lovastatin—ABCB1—cerebellum—germ cell cancer	0.000117	0.0011	CbGeAlD
Lovastatin—Dizziness—Methotrexate—germ cell cancer	0.000116	0.00105	CcSEcCtD
Lovastatin—Vomiting—Methotrexate—germ cell cancer	0.000111	0.00101	CcSEcCtD
Lovastatin—HDAC2—RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription—H2AFZ—germ cell cancer	0.000111	0.00662	CbGpPWpGaD
Lovastatin—Rash—Methotrexate—germ cell cancer	0.00011	0.000997	CcSEcCtD
Lovastatin—Dermatitis—Methotrexate—germ cell cancer	0.00011	0.000996	CcSEcCtD
Lovastatin—Headache—Methotrexate—germ cell cancer	0.00011	0.00099	CcSEcCtD
Lovastatin—Nausea—Methotrexate—germ cell cancer	0.000104	0.000939	CcSEcCtD
Lovastatin—ITGAL—Adaptive Immune System—KITLG—germ cell cancer	0.000104	0.0062	CbGpPWpGaD
Lovastatin—SLCO1A2—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.0001	0.00601	CbGpPWpGaD
Lovastatin—HDAC2—Neural Crest Differentiation—FGFR3—germ cell cancer	9.94e-05	0.00595	CbGpPWpGaD
Lovastatin—SLCO1A2—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	9.89e-05	0.00592	CbGpPWpGaD
Lovastatin—ABCB1—brain—germ cell cancer	9.54e-05	0.000897	CbGeAlD
Lovastatin—HDAC2—NOTCH1 Intracellular Domain Regulates Transcription—MYC—germ cell cancer	9.26e-05	0.00554	CbGpPWpGaD
Lovastatin—ABCB1—lymph node—germ cell cancer	9.22e-05	0.000867	CbGeAlD
Lovastatin—SLCO1B1—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	8.58e-05	0.00514	CbGpPWpGaD
Lovastatin—SLCO1B1—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	8.46e-05	0.00506	CbGpPWpGaD
Lovastatin—HDAC2—Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants—MYC—germ cell cancer	8.05e-05	0.00482	CbGpPWpGaD
Lovastatin—HDAC2—Chromatin modifying enzymes—H2AFZ—germ cell cancer	7.88e-05	0.00472	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	7.8e-05	0.00467	CbGpPWpGaD
Lovastatin—ITGAL—Focal Adhesion—HRAS—germ cell cancer	7.74e-05	0.00463	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—FGFR3—germ cell cancer	7.7e-05	0.00461	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—FGF4—germ cell cancer	7.65e-05	0.00458	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—CD9—germ cell cancer	7.58e-05	0.00454	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—AVP—germ cell cancer	7.53e-05	0.00451	CbGpPWpGaD
Lovastatin—HDAC2—Notch Signaling Pathway—MYC—germ cell cancer	7.51e-05	0.0045	CbGpPWpGaD
Lovastatin—HDAC2—Transcription—H2AFZ—germ cell cancer	7.5e-05	0.00449	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	7.14e-05	0.00427	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	7.1e-05	0.00425	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—FGF4—germ cell cancer	7.08e-05	0.00424	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—KIT—germ cell cancer	7.07e-05	0.00423	CbGpPWpGaD
Lovastatin—HMGCR—AMPK Signaling—TP53—germ cell cancer	6.99e-05	0.00419	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of Telomerase—MYC—germ cell cancer	6.89e-05	0.00412	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—NR0B1—germ cell cancer	6.88e-05	0.00412	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	6.67e-05	0.00399	CbGpPWpGaD
Lovastatin—HDAC2—FBXW7 Mutants and NOTCH1 in Cancer—MYC—germ cell cancer	6.65e-05	0.00398	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—KITLG—germ cell cancer	6.28e-05	0.00376	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—germ cell cancer	6.05e-05	0.00362	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of nuclear SMAD2/3 signaling—MYC—germ cell cancer	5.99e-05	0.00359	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—DNMT3L—germ cell cancer	5.96e-05	0.00357	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—KITLG—germ cell cancer	5.81e-05	0.00348	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—RARS—germ cell cancer	5.55e-05	0.00332	CbGpPWpGaD
Lovastatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	5.26e-05	0.00315	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	5.1e-05	0.00305	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	5.03e-05	0.00301	CbGpPWpGaD
Lovastatin—HDAC2—Neural Crest Differentiation—MYC—germ cell cancer	5.02e-05	0.00301	CbGpPWpGaD
Lovastatin—HDAC2—Glucocorticoid receptor regulatory network—TP53—germ cell cancer	4.87e-05	0.00292	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NOTCH—MYC—germ cell cancer	4.72e-05	0.00283	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—FGFR3—germ cell cancer	4.67e-05	0.0028	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	4.64e-05	0.00278	CbGpPWpGaD
Lovastatin—SLCO1A2—SLC-mediated transmembrane transport—AVP—germ cell cancer	4.63e-05	0.00277	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	4.58e-05	0.00274	CbGpPWpGaD
Lovastatin—HMGCR—Integrated Breast Cancer Pathway—MYC—germ cell cancer	4.55e-05	0.00272	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	4.36e-05	0.00261	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—FGFR3—germ cell cancer	4.32e-05	0.00259	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	4.31e-05	0.00258	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	4.3e-05	0.00257	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—KIT—germ cell cancer	4.29e-05	0.00257	CbGpPWpGaD
Lovastatin—HDAC2—Cell Cycle—TP53—germ cell cancer	4.09e-05	0.00245	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—KIT—germ cell cancer	3.97e-05	0.00238	CbGpPWpGaD
Lovastatin—SLCO1B1—SLC-mediated transmembrane transport—AVP—germ cell cancer	3.96e-05	0.00237	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—SLC2A3—germ cell cancer	3.96e-05	0.00237	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—SLC22A3—germ cell cancer	3.9e-05	0.00233	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NOTCH—TP53—germ cell cancer	3.88e-05	0.00232	CbGpPWpGaD
Lovastatin—HDAC2—Disease—SLC2A3—germ cell cancer	3.78e-05	0.00226	CbGpPWpGaD
Lovastatin—HMGCR—Integrated Breast Cancer Pathway—TP53—germ cell cancer	3.74e-05	0.00224	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—TP53—germ cell cancer	3.69e-05	0.00221	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	3.68e-05	0.00221	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—HRAS—germ cell cancer	3.53e-05	0.00212	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	3.34e-05	0.002	CbGpPWpGaD
Lovastatin—HDAC2—Factors involved in megakaryocyte development and platelet production—TP53—germ cell cancer	3.25e-05	0.00195	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—SLC2A3—germ cell cancer	3.23e-05	0.00193	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—SLC22A3—germ cell cancer	3.18e-05	0.0019	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—CRABP1—germ cell cancer	3.18e-05	0.0019	CbGpPWpGaD
Lovastatin—HDAC2—Direct p53 effectors—TP53—germ cell cancer	3.17e-05	0.0019	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—HRAS—germ cell cancer	3.05e-05	0.00183	CbGpPWpGaD
Lovastatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	2.89e-05	0.00173	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—SLC2A3—germ cell cancer	2.74e-05	0.00164	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—SLC22A3—germ cell cancer	2.7e-05	0.00162	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—CRABP1—germ cell cancer	2.59e-05	0.00155	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—SLC2A3—germ cell cancer	2.39e-05	0.00143	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—TP53—germ cell cancer	2.38e-05	0.00142	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—SLC22A3—germ cell cancer	2.35e-05	0.00141	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—AVP—germ cell cancer	2.35e-05	0.00141	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—SLC2A3—germ cell cancer	2.23e-05	0.00133	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—CRABP1—germ cell cancer	2.2e-05	0.00132	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—SLC22A3—germ cell cancer	2.2e-05	0.00131	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	2.18e-05	0.00131	CbGpPWpGaD
Lovastatin—HDAC2—Disease—FGF4—germ cell cancer	2.17e-05	0.0013	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	2.15e-05	0.00129	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—AVP—germ cell cancer	2.14e-05	0.00128	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	2.12e-05	0.00127	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—H2AFZ—germ cell cancer	2.09e-05	0.00125	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—SLC2A3—germ cell cancer	2.04e-05	0.00122	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—SLC22A3—germ cell cancer	2.01e-05	0.0012	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—AVP—germ cell cancer	2.01e-05	0.0012	CbGpPWpGaD
Lovastatin—HDAC2—Disease—H2AFZ—germ cell cancer	1.94e-05	0.00116	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—CRABP1—germ cell cancer	1.92e-05	0.00115	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	1.89e-05	0.00113	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—SLC2A3—germ cell cancer	1.88e-05	0.00112	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—HRAS—germ cell cancer	1.85e-05	0.00111	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—SLC22A3—germ cell cancer	1.85e-05	0.00111	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—CRABP1—germ cell cancer	1.79e-05	0.00107	CbGpPWpGaD
Lovastatin—HDAC2—Disease—KITLG—germ cell cancer	1.78e-05	0.00107	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—OXT—germ cell cancer	1.78e-05	0.00107	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	1.72e-05	0.00103	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—HRAS—germ cell cancer	1.71e-05	0.00103	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—CRABP1—germ cell cancer	1.64e-05	0.000982	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—FGF4—germ cell cancer	1.52e-05	0.00091	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—CRABP1—germ cell cancer	1.51e-05	0.000902	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—H2AFZ—germ cell cancer	1.36e-05	0.000813	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—SLC2A3—germ cell cancer	1.36e-05	0.000812	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—SLC22A3—germ cell cancer	1.34e-05	0.000799	CbGpPWpGaD
Lovastatin—HDAC2—Disease—FGFR3—germ cell cancer	1.33e-05	0.000793	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—KITLG—germ cell cancer	1.25e-05	0.000748	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—AVP—germ cell cancer	1.22e-05	0.000731	CbGpPWpGaD
Lovastatin—HDAC2—Disease—KIT—germ cell cancer	1.22e-05	0.000728	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—SLC2A3—germ cell cancer	1.17e-05	0.000703	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—SLC22A3—germ cell cancer	1.16e-05	0.000692	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—TP53—germ cell cancer	1.14e-05	0.00068	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—CRABP1—germ cell cancer	1.09e-05	0.000652	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—HRAS—germ cell cancer	1.09e-05	0.00065	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—SLC2A3—germ cell cancer	1.05e-05	0.000627	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—SLC22A3—germ cell cancer	1.03e-05	0.000618	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—SLC2A3—germ cell cancer	1.02e-05	0.000612	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—SLC22A3—germ cell cancer	1.01e-05	0.000603	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	1.01e-05	0.000603	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	9.74e-06	0.000583	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—SLC2A3—germ cell cancer	9.64e-06	0.000577	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—SLC2A3—germ cell cancer	9.56e-06	0.000572	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—SLC22A3—germ cell cancer	9.49e-06	0.000568	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CRABP1—germ cell cancer	9.43e-06	0.000564	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—SLC22A3—germ cell cancer	9.41e-06	0.000564	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—FGFR3—germ cell cancer	9.28e-06	0.000556	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—KIT—germ cell cancer	8.52e-06	0.00051	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CRABP1—germ cell cancer	8.42e-06	0.000504	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CRABP1—germ cell cancer	8.21e-06	0.000492	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	8e-06	0.000479	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CRABP1—germ cell cancer	7.74e-06	0.000463	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CRABP1—germ cell cancer	7.67e-06	0.000459	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—MYC—germ cell cancer	7.21e-06	0.000432	CbGpPWpGaD
Lovastatin—HDAC2—Disease—MYC—germ cell cancer	6.7e-06	0.000401	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—SLC2A3—germ cell cancer	6.3e-06	0.000377	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—SLC22A3—germ cell cancer	6.21e-06	0.000372	CbGpPWpGaD
Lovastatin—HDAC2—Disease—HRAS—germ cell cancer	5.26e-06	0.000315	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CRABP1—germ cell cancer	5.06e-06	0.000303	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MYC—germ cell cancer	4.69e-06	0.000281	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TP53—germ cell cancer	3.85e-06	0.000231	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—HRAS—germ cell cancer	3.68e-06	0.00022	CbGpPWpGaD
